SGMO

SANGAMO THERAPEUTICS, INC

CIK 0001001233 · OTC

OTCHealth CareBiological Products, (No Diagnostic Substances)

$0.07

↑ 0.00 (0.00%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Overall read: NeutralOverall score · based on 3/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap

$30.66M

P/E Ratio

-0.25

EPS

-0.44

Dividend Yield

Not covered

52W Position

Beta

1.93

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

-1.62

P/S

0.89

EV/Revenue

0.09

ROE

650.6%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 1%

$0.06$0.77

Latest Financials

2025-12-31 FY

Revenue

$39.55M

Net Income

-$122.93M

Total Assets

$59.74M

Free Cash Flow

-$97.31M

SGMO

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

SGMO

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news